Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-030727

SVP, Head of Global Commercial sold 16,334 shares at $45.02 ($735,357)

  • SVP, Head of Global Commercial acquired 16,334 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Porter Derrell SVP, Head of Global Commercial 2018-05-15 Option exercise +16,334 $14.30 $233,576 28,834 D: show line 1 in the form
Porter Derrell SVP, Head of Global Commercial 2018-05-15 Sale −16,334 $45.02 $735,357 12,500 D: show line 2 in the form
Open-market sales · 16,334 sh · avg $45.02 · $735,357

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Porter Derrell SVP, Head of Global Commercial 2018-05-15 Option exercise · Employee Stock Option (Right to Buy) −16,334 113,666 D: show line 3 in the form
Loading xslF345X03/doc4.xml…